Time BioVentures

Phantom Neuro is a neurotechnology company dedicated to enhancing robotic limb rehabilitation through innovative muscle-machine interfaces. By integrating neurotechnology with robotic systems, the company focuses on improving mobility and facilitating precise control of robotic limbs, which allows for more natural movement and better user experiences. Phantom Neuro employs a minimally invasive approach, aiming to provide effective rehabilitation tools and improve the quality of life for individuals with mobility challenges. Additionally, the company explores various applications of its technologies, contributing to the advancement of assistive robotics and addressing the needs of individuals with limb differences.

Conceivable Life Sciences is a company focused on revolutionizing in vitro fertilization (IVF) through automation. It is developing the first fully automated IVF laboratory, which aims to democratize access to fertility treatments. By utilizing advanced technologies and single-cell robotics, Conceivable Life Sciences operates IVF labs designed to streamline the IVF process, thereby making it more accessible for individuals and couples seeking to fulfill their dreams of parenthood. The company's innovative approach seeks to enhance the efficiency and effectiveness of IVF, ultimately contributing to improved outcomes for patients.

Rivermark Medical specializes in the development of minimally invasive treatments for Benign Prostatic Hyperplasia (BPH), a condition that affects urinary function in men. The company focuses on device therapies designed to effectively alleviate BPH symptoms with minimal side effects, ensuring a swift recovery for patients. Developed by urologists, Rivermark's innovative approach allows for procedures that require little to no downtime and eliminate the need for post-procedural catheters, enabling patients to quickly resume their normal daily activities.

Brightside Health, Inc. is a telemedicine platform based in San Francisco, California, focused on providing evidence-based mental health treatments for anxiety and depression. Established in 2017, the company offers a mobile application that facilitates personalized treatment experiences through video consultations, messaging, and ongoing support, including medication delivery. Brightside Health employs precision psychiatry and clinically proven therapeutic approaches to evaluate and monitor patients' mental health. Its platform provides tools and resources for lifestyle management, therapy referrals, and progress tracking, enabling individuals to access quality care and improve their well-being. The company was previously known as Good Measure, Inc. before rebranding in February 2018.

Commons Clinic is a multi-specialty healthcare provider based in Austin, Texas, established in 2021. The clinic focuses on delivering seamless medical treatment through a coordinated approach involving elite physicians. It offers comprehensive specialty and surgical care programs in various areas including pain management, orthopedics, women's health, and men's health. By emphasizing efficient and improved patient care, Commons Clinic aims to enhance the overall healthcare experience for its patients.

BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

Phantom Neuro is a neurotechnology company dedicated to enhancing robotic limb rehabilitation through innovative muscle-machine interfaces. By integrating neurotechnology with robotic systems, the company focuses on improving mobility and facilitating precise control of robotic limbs, which allows for more natural movement and better user experiences. Phantom Neuro employs a minimally invasive approach, aiming to provide effective rehabilitation tools and improve the quality of life for individuals with mobility challenges. Additionally, the company explores various applications of its technologies, contributing to the advancement of assistive robotics and addressing the needs of individuals with limb differences.

BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.

NanoMosaic is a biotechnology company focused on advancing early illness detection, prognostic monitoring, and biomarker identification through its innovative nanoneedle technology. The company's proprietary proteomic platform utilizes nanoneedles to enable precise protein detection and quantification. By integrating these capabilities onto a single chip, NanoMosaic aims to enhance the efficiency and accuracy of biomarker discovery and validation processes. This technology is designed to support the medical and healthcare industries in improving diagnostic capabilities and patient outcomes.

DeepSight Technology is a health technology company focused on enhancing diagnostic medical imaging through its innovative sensing technology. By integrating patented hardware, software, and artificial intelligence, DeepSight significantly improves image quality and extends the depth penetration of medical diagnostic ultrasounds. This advancement allows healthcare providers to utilize proprietary sensor technology that broadens the capabilities of diagnostic ultrasounds, ultimately benefiting public health and well-being. The company aims to make medical imaging safer, faster, more affordable, and more accessible, marking a substantial improvement in the field of diagnostic imaging.